Skip to main content
Media Coverage

Biotech firm receives patent for psilocybin-derived mental health therapeutics [Helio]

By October 2, 2023No Comments

A Boston-area biotechnology firm announced it has received a patent titled “Carboxylated Psilocybin Derivatives and Methods of Using” for its EVM301 series of molecules to treat a range of mental health disorders.

Full Article